CF PHARMTECH, INC. - H SHARES
(HKEX: 2652)
CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. The company focuses on complex products and platforms, innovative medicines, and medical devices. It also offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. The company was founded by Liang Wenqing and Li Li in 2007 and is headquartered in Suzhou, China.
20.880 -
-0.700
(-3.24%)
Range
19.160 - 22.020
(14.93%)
Open
21.520
Previous Close
21.580
Bid Price
20.720
Bid Volume
('000)
0.5
Ask Price
20.880
Ask Volume
('000)
0.5
Volume
('000)
634.2
Value
13,329,721
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
